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Objective: To evaluate the efficiency of biological sealant, an autologous fibrin glue, in dermatological surgery. Design: Randomized
clinical trial. Setting: The Dermatology Service of Hospital das Clínicas, Universidade de Campinas (UNICAMP), referral center.
Patients: 14 patients with malign epithelial cutaneoos tumors participated in the evaluation, each having two tumors, generally
facial and symmetrical, in order to perform a comparative evaluation on the same individual. Procedures: The glue was prepared
beforehand with a sample of autologous blood.  Surgical extirpation of the tumor was followed by grafts or second intention healing.
Outcomes: The efficiency of the sealant was then evaluated in relation to hemostasis, adhesion, surgical time and evolution of the
granulation tissue, clinically and histologically. Results: Immediate hemostasis and graft adhesion, with a significant reduction of
surgical time, and in the open wounds there was immediate hemostasis and a clinical increase in granulation tissue, but with no
histological differences among the groups on the 7th day. Conclusion: It is an adjuvant resource in skin cancer surgery.
Uniterms: Fibrin glue. Wound healing. Skin cancer. Dermatologic surgery.
INTRODUCTION
Notwithstanding the continuing development ofnew surgical techniques, some problems such asblood coagulation and healing still remain.
Dermatologic surgery  has increased rapidly but one
of its main indications is still the extirpation of malign
cutaneous tumors, especially basal cell and squamous cell
carcinomas. In such surgery, cutaneous tumors are often
extensive and cause great tissue loss, requiring the
utilization of grafts or, possibly, second intention healing.
Many dressings have been tried in order to help the
healing of these wounds and, currently, attention is more
directed towards those of a  biological nature.1
 The first experiments in the use of fibrinogen as a
tissue adhesive were carried out in 1940.2 The concept of
fibrin glue became realistic in the 1970’s, with the advent
of techniques for isolation and concentration of
coagulation factors. In 1972, the success of fibrin glue in
repairing a peripheral nerve was described.3 Since then,
there have been many reports of successes and the use of
fibrin glue has been extended into several areas of
medicine.4-8
Many surgeons have indicated fibrin glue as the ideal
sealant material and because of its human origin it is not
toxic towards tissue. Fibrin glue promotes firm adhesion
in seconds or minutes; it is reabsorbed within a few days
after application, contains tissue more rapidly and
decreases the risks of hematomas and graft losses.9-11
Fibrin glue is commercially available and is produced
from homologous plasmas. However, contamination risks,
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potentially related to the hepatitis C virus and HIV,12 have
discouraged its production in many countries.
There are also reports of the production of fibrin glue
by extraction of fibrinogen from animal serum, although
there is discussion about the possibility of hypersensitivity
reactions from heterologous proteins.13
Autologous fibrin glue may be produced from one
blood unit (500 ml). Fibrinogen is obtained from blood
via centrifugation and cryoprecipitation techniques and is
converted into fibrin glue by adding thrombin during
surgery. Fibrinogen may be stored in a freezer  at - 20°C
and can  be used for two years.
As previously mentioned, most dermatologic surgery
is performed for the  treatment of malign cutaneous tumors.
When flap or grafting reconstruction techniques are used,
the visualization of the tumor is difficult if there is a relapse.
Thus, second intention healing favors the follow-up of
surgical therapy.
Moreover, reconstruction techniques may become
impossible in individuals with extensive actinic injury, who
are likely to be deficient in cutaneous donor areas. Among
other factors which may favor second intention healing,
the reduction of surgical time and reduced patient
morbidity should be mentioned.
The use of fibrin glue in second intention healing is
relevant, since fibrin acts in the initial phase, facilitating
progression to subsequent phases.
The aim of this study was to evaluate the effectiveness
of autologous fibrin glue used in dermatological surgery
with skin grafts and second intention healing, studying
the hemostasy, adesivity, granulation tissue and surgical
time.
METHODS
This study evaluated the effectiveness of autologous
fibrin glue used in dermatological surgery under the
following conditions.
Fourteen white patients, male and female, coming
from the Dermatology Outpatient Department, Hospital
das Clínicas,Unicamp, ranging from 30 to 90 years old,
were evaluated. Patients presented histologically diagnosed
basal cell and squamous cell carcinomas, with
development as far as the reticular dermis. The individuals
selected needed to have two lesions, preferably on the face,
with a diameter of 1.0 to 5.0 cm.
Once the above criteria were defined, patients were
submitted to exeresis around the injury, with a 4.0 mm
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Figure 1 - Case 5: collocation of thrombin and fibrinogen, after
the excision of cutaneous tumor (BCC).
Figure 2 - Case 5: fast adhesion of the cutaneous graft.
Figure 3 - Case 5: complete integration of the skin graft 3 months
later.
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safety margin, under local anesthesia with 1% lidocaine
without vasoconstrictor.
The patients were divided into two randomized
groups by procedure: either reconstruction via graft or
second intention healing. The treatment of the lesions was
subdivided into four groups, according to the procedure:
A- Exeresis followed by graft, with use of fibrin glue;
B- Exeresis followed by graft, without use of fibrin glue;
C- Exeresis and second intention healing, with use of fibrin
glue;
D- Exeresis and second intention healing, without use of
fibrin glue.
Thus, procedures A and B were performed on the
same patient, preferably in symmetrical lesions, and so
were procedures C and D.
In the lesions submitted to cutaneous grafts, the
autologous fibrin glue was placed first, followed by
grafting. After graft adhesion, a dressing with 1%
garamycin cream was applied, followed by occlusion using
gauze and micropore-type adhesive tape. In control
injuries, grafting was placed in the usual manner with
suture using a black 5.0 single-strand thread, followed by
application of Brown’s dressing. The same garamycin
cream was also applied underneath the dressing.
In the lesions left for second intention healing, fibrin
glue was placed directly onto the base of the surgery,
followed by a dressing with 1% garamycin cream and
occlusion using gauze and adhesive tape. In controls,
garamycin cream was applied directly onto the base of the
surgery. All lesions received occlusive bandaging with
garamycin cream, changed daily for 7 days.
The tumours chosen for second intention healing
were those poorly delimited, where there were relapses or
sclerodermiform basal cell carcinomas.
All grafted injuries were evaluated on the 1st, 3rd,
7th and 30th post-operative days. Brown’s dressing was
removed after 72 hours, and the suture after 7 days.
The lesions left for second intention healing were
evaluated on the same days, although also applying fibrin
glue to the lesions of group C on the 1st, 3rd and 7th days.
Both groups had their occlusive bandaging changed daily.
A histological sample was taken from the lesions of
groups C and D for evaluation of the progress of second
intention healing on the 7th post-operative day. A tissue
fragment was collected using a 4 mm punch on the base
of the surgery, at a distance of 5 mm from the margin.
Processing of autologous fibrin glue
To produce autologous fibrin glue, only 50 ml of blood
was drawn from each patient. The blood was drawn using
sodium citrate at 3.8%, in a proportion of 9:1, centrifugated
for 10 minutes at 3000 rpm to separate the plasma.
Purification of fibrinogen
The purification of plasmatic fibrinogen was
performed via the glycine precipitation technique. Under
controlled temperature and concentration, glycine
separates out only the plasmatic fibrinogen.
Anhydrous magnesium sulphate and barium
sulphate, at a final concentration of 20 mM/l and 90g/l,
respectively, were added to 25 ml of the plasma. After
agitation for one hour, the supernatant was centrifugated
and separated. This procedure was repeated once more.
After measuring the supernatant plasma, glycine was
slowly added to a final concentration of 2.2 M/l. Again,
the product was agitated for 30 minutes followed by
centrifugation for 20 minutes.
The supernatant was discarded and the deposit was
resuspended to the initial plasmatic volume, using 0.055
M sodium citrate, at pH 7.4. Then, glycine precipitation
was carried out again.
Finally, the deposit was resuspended in PBS to a
final concentration of 800 mg/ml, aliquoted and frozen
at -20°C.
Use of fibrin glue
After the ablation of the tumoral lesion, autologous
fibrinogen and human thrombin were concomitantly
applied, resulting in a viscous substance. This material
was applied either via separate syringes or as a spray. Then,
either cutaneous grafting was placed over this material or
the wound was left for second intention healing. In this
latter situation, the fibrin glue was reapplied on the 1st,
3rd and 7th post-operative days.
RESULTS
In Table 1, tumour size, histological type, location
and surgical type are described. All excised tumours were
histopathologically examined and found to be free from
neoplastic cells at the borders.
Wounds with grafts
In the lesions submitted to cutaneous grafting and
covered with fibrin glue, hemostasis was instantaneous
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and the adhesion of the graft was also firm and immediate.
These benefits noticeably reduced surgical time to around
3 minutes.
In the control injuries, where Brown’s dressing was
used, the surgical time was much longer, approximately
20 minutes.
The 7th and 30th day evaluations showed no
differences between the groups.
Wounds with second intention healing
Lesions left for second intention healing using fibrin
glue showed immediate hemostasis and, clinically, more
exuberant granulation tissue in the immediate intra-
operative and post-operative periods. But from the 7th
post-operative day,  the evolution of the injuries was
similar.
Histological examination of the bases of the
wounds left for second intention healing was performed
via biopsy taken at 5 mm from the healing margin of
the surgical wound on the 7th day, in 4 wounds left for
second intention healing (two with and two without
fibrin glue). Macroscopically, the fragments presented
tissue in the granulation phase. However, there was no
histological difference between the fragments with and
without fibrin glue when evaluated with hematoxylin-
eosin staining.
DISCUSSION
The use of fibrin glue has been described in many
situations, such as repair of the peripheral nerves and other
visceras, fistula occlusion, surgery of cerebral tumors, skin
grafting and application in burned patients.4,5,7,9,11,14-18,21,22
The continuing evolution in the preparation and use of
fibrin glue is emphasized in the literature.
Reconstruction in dermatological surgery treating
malignant cutaneous tumors may be made difficult due to
extensive cutaneous involvement or location in anatomical
areas with difficult access. Great tissue loss requires the
use of grafting or, possibly, second intention healing. The
latter is indicated for poorly delimited relapsing tumors
which require a long follow-up without reconstruction, so
as not to make visualization of new tumoral growth difficult.
In our study, the use of fibrin glue in these two
situations, the application of grafting and second intention
healing, was examined as three topics:
Application of cutaneous grafting
The use of fibrin glue in the intra-operative period greatly
facilitated surgery because hemostasis was immediate. The
adhesion of the grafts was firm and suture was not necessary,
thus reducing the surgical time when compared to control
Table 1
Patients divided according to tumor site, histopathological classification and surgical type.
No. Patient Histology* Diameter** Site Surgical type
1 DPC BCC 2.0cm/2.0cm Face Graft
2 AS BCC 2.0cm/2.0cm Face Graft
3 GPM BCC 1.5cm/1.5cm Face Graft
4 WS BCC 1.5cm/1.0cm Face Graft
5 DB BCC 2.0cm/2.5cm Face Graft
6 WB BCC 2.5cm/2.0cm Face Graft
7 ACV BCC 2.5cm/2.0cm Face Second intention
8 LBP BCC 2.5cm/2.5cm Face Second intention
9 AF SCC 1.0cm/1.5cm Face/sternum Second intension
10 JC BCC and SCC 2.0cm/2.0cm Face Second intention
11 CM BCC and SCC 3.0cm/3.0cm Face Second intention
12 II SCC 3.0cm/2.0cm Face Second intention
13 SN BCC and SCC 2.0cm/2.0cm Face Second intention
14 LLS BCC 4.0cm/3.5cm Face Second intention
* Histopathological examination was performed before surgery and was defined as BCC (Basal Cell Carcinoma) or SCC
(Squamous Cell Carcinoma).
** The diameter considered was the greatest axis of the surgical area obtained after excision of the tumorous part.
Rev Paul Med 1998;116(4):1747-52 Moraes AM, Annichino-Bizzacchi JM, Rossi ABR. Use of autologous fibrin glue in dermatologic
surgery application of skin graft and second intention healing.
1751
injuries. These findings corroborate those of Dahlstrom et al;5
Gibble and Ness;1 Lilius;8 and Tildrick and Warner.21
Efficient hemostasis is reported in various studies,
and as the principal advantage of fibrin glue in surgery on
organs with nonsuturable hemorrhage, such as liver, spleen
and retroperitoneal surfaces.12,18 The firm adhesion that
facilitates the joining of tissues is also reported in various
studies involving surgery on internal organs.7,14-16,18-20
In a preliminary study on 12 patients, Bizzachi et al.11
used fibrin glue for the application of cutaneous grafting after
exeresis of facial tumors. Our results corroborate that report,
with a reduction of surgical time and good esthetic results.
Due to the rapid and efficient hemostasis, it was
observed during clinical evolution that there was no
development of hematomas and if they showed up at all,
they were small and did not develop a corresponding
necrosis. Up until now, there has not been any epitheliolisis
in the grafts with fibrin glue.
Most patients submitted to dermatological surgery are
carriers of tumoral actinic lesions resulting from exposure
to solar radiation. The availability of fibrin glue is yet another
means for performing reconstruction in patients who
frequently have to undergo several surgical operations.
Second intention healing
Fibrin glue has also been shown to be useful in the
intra-operative period in lesions left  for second intention
healing, due to the rapid hemostasis.
In the evolution of healing, development of more
evident granulation tissue occurred in lesions with fibrin
glue. Since fibrin glue was applied on the 1st, 3rd, and 7th
days in this group, the supposition was that the cell migration
stimulus triggered in the repair was higher in these cases.
The application of glue was not recommended after this
time, as it is known that the fundamental role of fibrin is
played in the initial phase of the healing period. Moreover,
the maintenance of an aqueous medium in the wound is a
determining factor in the evolution of healing.2,6
Brown et al reported a reduction in wound retraction
in cutaneous grafts applied with fibrin glue.13 In this study,
the reduction in retraction of grafted wounds was attributed
to the graft itself, because the evolution of healing was
similar to that of the control group.
In wounds left  for second intention healing, glue did
not interfere with the natural retraction of the wound. On the
contrary, in the initial phase of healing, there was a real natural
retraction, more rapid than in the cases without fibrin glue.
Histopathological examination of granulation tissue
from open wounds on the 7th day, with and without fibrin
glue, did not show any evolutive differences regarding
healing and inflammatory cellular infiltration.
In another study performed experimentally on animal
wounds using commercially produced heterologous glue,
the inflammatory layer showed greater cellular content and
fibroblasts had higher replication activity on the 5th day.3
The divergence of these findings is probably due to the small
size of the fragments collected for our histopathological
examinations, which was not the case in Galleti’s study,3 in
which the wounds were studied histologically after their
complete ablation. The histology of these samples  permitted
complete evaluation of the center and depth of the wounds;
this was not seen in small individual fragments.
The proliferation of keratinocytes in a matrix
containing substrate with fibrin seems to be favored, as
shown in the studies of Ronfard et al. These authors used
fibrin glue in the culture of keratinocytes for the treatment
of burned patients. Thus, the use of fibrin glue may favor
the epithelization of open wounds.17,21
In this study, there was no secondary infection in
any of the cases although all the wounds received
garamycin cream. It was noticeable that in the cases where
fibrin glue was used, the antibiotic cream remained
completely isolated, without becoming mixed up with the
glue. This protective effect of fibrin glue against secondary
infection was described by Jabs et al.10
Preparation of fibrin glue
One of the restrictions on the use of homologous
fibrin glue is the possibility of contamination by virus,
including the hepatitis C virus and HIV. The use of
autologous fibrin glue excludes the risk of contamination,
as long as the patient’s own blood is used. Blood sampling
for the elaboration of the autologous product was a
procedure completely accepted by all patients.
In most of the studies reported, the preparation of
autologous fibrin glue is made from a 500 ml blood
volume. This is a limiting factor for aged patients. The
technique of fibrinogen isolation we used permitted the
preparation of a good quality fibrin glue in adequate
quantities, drawing only 50 ml of blood from each patient.
A limiting factor for the use of fibrin glue is its cost,
because the products commercially available are very
expensive. Thus, another advantage of autologous fibrin
glue is its low cost, although the patient has to go to hospital
for blood sampling.25
In summary, these results favor the use of fibrin glue
in surgery on dermatological tumors, either using grafts
or second intention healing, as it facilitates the intra-
operative period, reducing surgical time and favoring
clinical evolution and the resultant healing. The storing
of fibrin facilitates multiple surgical operations in patients
with several cutaneous tumoral lesions.
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RESUMO
Objetivo: Avaliar a eficácia de um selante biológico, a cola de fibrina autóloga, na cirurgia dermatológica. Tipo de estudo:
Estudo prospectivo, randomizado. Participantes: 14 doentes com dois tumores cutâneos epiteliais malignos, principalmente
faciais e simétricos, para avaliação comparativa no mesmo indivíduo. Local: Serviço de Dermatologia do Hospital de Clínicas
da UNICAMP. Procedimentos: A cola foi preparada, previamente, com amostra de 50 ml de sangue autólogo. Após a exérese
do tumor, seguiu-se a colocação de enxertos ou cicatrização por segunda intensão. Variáveis: Hemostasia, adesão, tempo
cirúrgico e evolução do tecido de granulação, clínica e histologicamente. Resultados: Os resultados com a cola mostraram
hemostasia e adesão imediata dos enxertos, com redução significativa do tempo cirúrgico e nas feridas abertas houve
hemostasia imediata e maior tecido de granulação clinicamente mas sem diferenças histológicas, no 7º dia, entre os grupos.
Conclusão: Concluiu-se que é recurso adjuvante na cirurgia do câncer de pele.
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